Skip to main content
رجوع
CNTA logo

Centessa Pharmaceuticals plc

جودة البيانات: 100%
CNTA
NASDAQ Healthcare Biotechnology
KWD 25.94
▼ KWD 1.12 (-4.14%)
القيمة السوقية: 3.49B
نطاق اليوم
KWD 25.82 KWD 27.83
نطاق 52 أسبوعًا
KWD 9.60 KWD 30.58
حجم التداول
1,533,123
متوسط 50 يوم / 200 يوم
KWD 25.21 / KWD 21.69
الإغلاق السابق
KWD 27.06

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -14.8 0.4
P/B 8.7 2.9
ROE % -73.9 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.3 0.2

النقاط الرئيسية

Debt/Equity of 0.29 — conservative balance sheet
Negative free cash flow of -142.09M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-73.93%
ROIC-29.07%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.29
Current Ratio9.25
Interest Coverage-19.93

التقييم

P/E Ratio
-14.79
P/B Ratio8.68
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -235.76M
ROE -73.93% ROA -40.87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -142.09M
ROIC -29.07% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.29 Current Ratio 9.25
Interest Coverage -19.93 Dividend Yield 0.00%
Valuation
P/E Ratio -14.79 P/B Ratio 8.68
P/S Ratio N/A PEG Ratio -0.26
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 3.49B Enterprise Value 3.22B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 6.85M 0.0 0.0 0.0
Net Income -235.76M -151.09M -216.21M -381.90M -10.66M
EPS (Diluted) -2.06 -1.57 -2.31 -4.24 -0.08
Gross Profit 0.0 6.85M 0.0 0.0 0.0
Operating Income -201.06M -171.28M -212.26M -374.87M -10.44M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 576.80M 360.25M 444.31M 629.64M 11.72M
Total Liabilities 175.25M 124.00M 108.14M 138.08M 8.62M
Shareholders' Equity 401.55M 236.24M 336.17M 491.55M 3.10M
Total Debt 117.23M 84.59M 69.80M 75.70M 5.63M
Cash & Equivalents 383.22M 128.03M 393.64M 595.08M 7.23M
Current Assets 536.41M 315.09M 437.75M 628.77M 11.17M
Current Liabilities 58.00M 39.39M 38.34M 24.64M 8.62M